Acorah Software Products - Accounts Production 19.2.350 false true true 29 February 2024 1 March 2023 false 1 March 2024 28 February 2025 28 February 2025 08409943 T G Fraser iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08409943 2024-02-29 08409943 2025-02-28 08409943 2024-03-01 2025-02-28 08409943 frs-core:CurrentFinancialInstruments 2025-02-28 08409943 frs-core:Non-currentFinancialInstruments 2025-02-28 08409943 frs-core:PlantMachinery 2025-02-28 08409943 frs-core:PlantMachinery 2024-03-01 2025-02-28 08409943 frs-core:PlantMachinery 2024-02-29 08409943 frs-core:ShareCapital 2025-02-28 08409943 frs-core:RetainedEarningsAccumulatedLosses 2025-02-28 08409943 frs-bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 08409943 frs-bus:FilletedAccounts 2024-03-01 2025-02-28 08409943 frs-bus:SmallEntities 2024-03-01 2025-02-28 08409943 frs-bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 08409943 frs-bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 08409943 frs-bus:Director1 2024-03-01 2025-02-28 08409943 frs-countries:EnglandWales 2024-03-01 2025-02-28 08409943 2023-02-28 08409943 2024-02-29 08409943 2023-03-01 2024-02-29 08409943 frs-core:CurrentFinancialInstruments 2024-02-29 08409943 frs-core:Non-currentFinancialInstruments 2024-02-29 08409943 frs-core:ShareCapital 2024-02-29 08409943 frs-core:RetainedEarningsAccumulatedLosses 2024-02-29
Registered number: 08409943
Panmedica Medical Distribution Limited
Financial Statements
For The Year Ended 28 February 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 08409943
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 3,755 -
3,755 -
CURRENT ASSETS
Stocks 5 270 2,641
Debtors 6 97,019 97,271
Cash at bank and in hand 28,477 924
125,766 100,836
Creditors: Amounts Falling Due Within One Year 7 (153,239 ) (69,221 )
NET CURRENT ASSETS (LIABILITIES) (27,473 ) 31,615
TOTAL ASSETS LESS CURRENT LIABILITIES (23,718 ) 31,615
Creditors: Amounts Falling Due After More Than One Year 8 (24,256 ) (26,183 )
NET (LIABILITIES)/ASSETS (47,974 ) 5,432
CAPITAL AND RESERVES
Called up share capital 9 200 200
Profit and Loss Account (48,174 ) 5,232
SHAREHOLDERS' FUNDS (47,974) 5,432
Page 1
Page 2
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
T G Fraser
Director
7 May 2026
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Panmedica Medical Distribution Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08409943 . The registered office is Leonard House, 5-7 Newman Road, Kent, BR1 1RJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The accounts have been prepared on a going concern basis, which is dependent on the continued support of the director who has indicated his willingness to support the company for the foreseeable future.  The director therefore considers it appropriate to prepare the financial statements on a going concern basis.
2.3. Turnover
Revenue is recognised to the extent that the company obtains the right to consideration in exchange for its performance. Revenue is measured at the fair value of the consideration received, excluding discounts, rebates, VAT and other sales taxes or duty. 
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. No depreciation is provided in the year of acquisition. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 20% on cost
2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.6. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
Page 3
Page 4
4. Tangible Assets
Plant & Machinery
£
Cost
As at 1 March 2024 -
Additions 4,694
As at 28 February 2025 4,694
Depreciation
As at 1 March 2024 -
Provided during the period 939
As at 28 February 2025 939
Net Book Value
As at 28 February 2025 3,755
As at 1 March 2024 -
5. Stocks
2025 2024
£ £
Stock 270 2,641
6. Debtors
2025 2024
£ £
Due within one year
Trade debtors 11,726 11,726
Prepayments and accrued income 148 -
Other debtors 82,802 55,074
VAT 2,343 1,491
Director's loan account - 28,980
97,019 97,271
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 4,085 5,205
Bank loans and overdrafts 6,000 6,000
Other taxes and social security 1,730 -
Other creditors 1,611 26,611
Accruals and deferred income 6,644 6,644
Amounts owed to group undertakings 109,908 -
Amounts owed to parent undertaking 23,261 24,761
153,239 69,221
8. Creditors: Amounts Falling Due After More Than One Year
2025 2024
£ £
Bank loans 24,256 26,183
9. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 200 200
Page 5